Article
Kras-driven heterotopic tumor development from hepatobiliary organoids
1 Feb 2019
Abstract excerpt
Cancers arising from the biliary tract are refractory to conventional therapies, requiring the development of novel therapeutics. However, only a limited number of genetically engineered mouse models have been created, partly because of time-consuming work required. Besides, liver-specific gene manipulation mostly resulted in concurrent development of hepatocellular carcinoma, another type of liver cancer, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
